Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00253630What this trial is testingVorinostat in Treating Patients With Low-Grade Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Study completedNCT00002779What this trial is testingFludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 34
Testing effectiveness (Phase 2)Looking for participantsNCT04883437What this trial is testingAcalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin LymphomasWho this might be right forGrade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+5 more Emory University 49
Testing effectiveness (Phase 2)Study completedNCT00003849What this trial is testingRituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 39
Early research (Phase 1)Active Not RecruitingNCT05621096What this trial is testingLow Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin LymphomaWho this might be right forDLBCL - Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma+4 more University of Nebraska 33
Not applicableStudy completedNCT00387023What this trial is testingRadioimmunotherapy With 90Y Zevalin for Orbital LymphomaWho this might be right forNon-Hodgkin's LymphomaLymphoma M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT05783609What this trial is testingEpcoritamab and Rituximab for First-line Follicular LymphomaWho this might be right forFollicular LymphomaLow Grade Non-Hodgkin's Lymphoma, Adult Reid Merryman, MD 100
Testing effectiveness (Phase 2)Study completedNCT00003615What this trial is testingDenileukin Diftitox in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Eastern Cooperative Oncology Group 77
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22
Early research (Phase 1)Study completedNCT00060684What this trial is testingDose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more CTI BioPharma 30
Not applicableStudy completedNCT00003196What this trial is testingLow-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Ended earlyNCT00041288What this trial is testingStudy Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLLWho this might be right forLeukemiaLymphoma University of Texas Southwestern Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00784927What this trial is testingLenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin LymphomaWho this might be right forLymphoma Mayo Clinic 36
Testing effectiveness (Phase 2)Ended earlyNCT02501473What this trial is testingStudy of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)Who this might be right forFollicular Low Grade Non-Hodgkin's Lymphoma Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 52
Not applicableStudy completedNCT00014235What this trial is testingFludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more Fred Hutchinson Cancer Center 160
Testing effectiveness (Phase 2)UnknownNCT00007839What this trial is testingBeta Alethine in Treating Patients With Low-Grade LymphomaWho this might be right forLymphoma LifeTime Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT00079443What this trial is testingFR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's LymphomaWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Small Lymphocytic Lymphoma National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00596804What this trial is testingSafety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's LymphomaLymphoma, DiffuseLymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Gilead Sciences 39